MassachusettsState Snapshot for Children

In this comparison, the NHQDR measures for Massachusetts for the most recent data year and the baseline year are compared to the average of all States.

Due to changes in methodology, including a transition from International Classification of Diseases, Ninth Revision (ICD-9) to Tenth Revision (ICD-10) codes and updates to the Quality Indicators software, the current measure set does not contain AHRQ Quality Indicator measure results based on Healthcare Cost and Utilization Project (HCUP) data. These changes to the measure set had a significant impact on overall meter scores, so they are not provided at this time. When data become available, State scores will again be included.

Measures Better Than Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine Total 2017 92.6 Better than Average 2000 87.7 Better than Average
Children ages 19-35 months who received 3 or more doses of polio vaccine Total 2017 96.1 Better than Average 2000 94.1 Better than Average
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine Total 2017 98.3 Better than Average 2000 96.1 Better than Average
Children ages 19-35 months who received 1 or more doses of varicella vaccine Total 2017 97.6 Better than Average 2000 79.5 Better than Average
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine Total 2017 94.9 Better than Average 2008 61.2 Better than Average
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine Total 2017 92.5 Better than Average 2008 46.9 Average
Adolescent males ages 13-15 who received 3 or more doses of human papillomavirus (HPV) vaccine Total 2017 45.1 Better than Average Missing
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 2017 96.4 Better than Average 2008 49.8 Average
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 2017 95.8 Better than Average 2008 32.3 Average
Measures That Are Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine Total 2017 92.9 Average 2000 93.3 Better than Average
Infants born in the calendar year who received breastfeeding exclusively through 3 months Total 2016 47.7 Average Missing